Sensex: 73,832.55 (2.30%)

Nifty: 23,622.90 (1.99%)

anubhai angaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

Contact Us
Apply For IPO

MARKET

IPO Synopsis
Goldline Pharmaceutical Ltd
Registered Office: 103 F-1 Leela Apartment Shilpa, HSG Society Shanidham Narendra, Nagpur - 440015, Maharashtra
Phone: 1
Email: 1
Website: 1
Initial public issue of 27,00,000 equity shares of face value of Rs. 10/- each ("Equity Shares") of Goldline Pharmaceutical Limited ("Issuer" or "The" "company") at an issue price of Rs. 43 per equity share (including a share premium of Rs. 33 per equity share) for cash, aggregating to Rs. 11.61 Crores ("Public Issue") out of which 1,38,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 43 per equity share for cash, aggregating Rs. 0.59 Crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of 25,62,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 43 per equity share for cash, aggregating up to Rs. 11.02 Crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 28.13% and 26.69% respectively of the post-issue paid-up equity share capital of the company. Price Band is Rs. 43 per equity share of face value of Rs. 10/- each. The floor price is 4.3 times of the face value. Bids can be made for a minimum of Two lot and in multiples of 3,000 equity shares thereafter.
Issue Money Payable On
Opens On Closes On Application Allotment
12-May-2026 14-May-2026 43.00 - 0.00 0.00 - 0.00
Cr. Lead Managers to the Issue
Project Cost 10.06
Project Financed through Current Offer 11.61
Post Issue Equity Share Capital 9.60
Issue Price 43.00
Projects
Repayment of all or a portion of certain outstanding borrowings availed by its company
General Corporate Purpose
Promoted By
Amol Laxmikant Mujumdar
Swapan Premprakash Khandelwal
Asha Swapan Khandelwal
BSE - SME
Registrar to the Issue
Bigshare Services Pvt Ltd
Attention Investor
As per CDSL communiqué Kindly update your Email ID, Mobile Number & Income Range in CDSL demat Account on or before 31st May 2021, Non Compliance Account will be INACTIVE after 31st May 2021. | Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.  | "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." | "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."    Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors.